- Interim Results for six months ended 31 August 2023
- Notice – Interim Results for the six months ended 31 August 2023
- Letter to Shareholders – 10 July 2023
- Annual Integrated Report 2023
- Notice – Results Presentation – 5 July 2023
- Dividend Declaration Letter – 12 June 2023
- Consolidated AFS Lenmed Investments Limited and its Subsidiaries
- Chairman Letter – 4 May 2023
- Invite to stakeholders
- Interim results for the six months ended 31 August 2022
- Chairman Letter – 15 Sept 2022
- Annual Integrated Report 2022
- Annual General Meeting Notice 2022
- Shareholder Results Presentation – 14 June 2022
- Notice – Results Presentation Scheduled for 14 June 2022.
- Audited Financial results for year ending 28 February 2022
- Audited Financial Statements presentation Letter – 02 June 2022
- Lenmed Dividend Notice – 02 June 2022
- Interim results for the six months ended 31 August 2021
- Chairman’s Letter to Shareholders
- Letter to Shareholders
- Annual Integrated Report 2021 and Notice of AGM
- Lenmed King IV™ Overview
- Interim results for the six months ended 31 August 2020
- Annual Integrated Report 2020
- Audited financial results for the year ending February 2020
- Interim results for the six months ended 31 August 2019
- Annual Integrated Report 2019 and notice of AGM
- Annual Integrated Report 2019 and notice of AGM – PDF
- Preliminary Statements 2019
- Unaudited Financials 2018
- Annual Integrated Report 2018
- Preliminary Statements 2018
- Interim Results 2017
- Annual Integrated Report 2017
- Preliminary Statements 2017
- Annual Integrated Report 2016
- Unaudited Financials 2016
- Preliminary Statements 2016
- Annual Integrated Report 2015
- Annual Integrated Report 2014
- Annual Integrated Report 2013
- Annual Integrated Report 2012
- Annual Integrated Report 2011
- Annual Integrated Report 2010
- Annual Integrated Report 2009
